Next-generation ovarian cancer therapy: Engineered Vδ2 T cells show promise in preclinical trials Post author: Post published:November 13, 2023 Post category:uncategorized A prospective path for allogeneic cellular immunotherapies. You Might Also Like Groundbreaking study unveils key mechanism for neuronal identity regulation March 21, 2025 Cell-by-cell analysis reveals brain changes in Tourette syndrome April 9, 2025 SRF announces grant to support research on SynGAP-Related Disorder in adults April 4, 2024